The Wall Street Journal

14743 Voos
The Wall Street Journal

The Wall Street Journal

@WSJ

Sign up for our newsletters and alerts: https://t.co/QevH0DLQi8 | Got a tip? https://t.co/iXIigdPjEZ | For WSJ customer support: https://t.co/DZgH9n53qg

wsj.comIngressou em março de 2026
Since John D. Rockefeller handed out dimes, the world’s richest have given away their money in very different ways. Now they are bypassing charity—and writing a new social contract. 🔗: on.wsj.com/4yErWN5
As she was putting the finishing touches on her genre-bending album “Lux,” there was nothing for Rosalía to do but binge “Love Island.”⁠ Watch Rosalía’s full interview with WSJ. Magazine: 🎥 on.wsj.com/4zdCcNJ
Rep. Alexandria Ocasio-Cortez, aka AOC, has softened her tactics and pursued voters and lawmakers in both parties. To reach her biggest goals, she‘ll need the far-left base—and everybody else. 🔗 on.wsj.com/4zNNA2u
Martin McDonagh has total creative control over his films, resulting in a slew of Oscar nominations and a cinematic style all his own. Read more from The Innovators Issue of WSJ. Magazine: 🔗 on.wsj.com/4kf4ySP
Five years ago, the engineers on the frontier of artificial intelligence trained a model to solve thousands of basic math problems. Then they put it to the test. Now it’s your turn. 🔗 on.wsj.com/4ii9fsG
Boston's Logan International Airport is looking for a "voice that feels like home" to greet and guide the roughly 130,000 people who fly in and out of the airport every day. Judges have narrowed it down to eight finalists, and are leaving the public to vote next. Read more: 🔗 on.wsj.com/4illoNs
The decision hands Bayer the first ever approval for a Factor XIa inhibitor, which aim to slow the activity of a protein that regulates how the body forms clots without increasing the risk of bleeding. on.wsj.com/4zWzJXV
The wealthy have long torn down older houses, or those needing extensive renovation. But even new houses are now being purchased for nine-figure sums and then razed to make way for custom builds. on.wsj.com/4ijXlOW
The Swiss drugmaker expects a pill it is developing to become the new standard treatment for an advanced form of lung cancer, and the company’s first shot at an emerging field within the oncology market. on.wsj.com/4yFlLs8
AstraZeneca is readying to file the first of a new portfolio of targeted cancer drugs for regulatory approval, moving to cement its position in one of the fastest-growing corners of the oncology market. on.wsj.com/4BrRQGs